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Abstract
Background: In 2011 the largest measles outbreak in North America in a decade occurred in Quebec, Canada with
over 700 cases. In contrast, measles activity in neighbouring province Ontario remained low (8 cases). Our objective
was to determine the extent to which the difference could be explained by differing travel patterns.
Methods: We explored the relationship between measles cases over 2007–2011, by importation classification, in
Quebec and Ontario in relation to global travel patterns to each province using an ecological approach. Global
measles exposure was estimated by multiplying the monthly traveler volume for each country of origin into
Quebec or Ontario by the yearly measles incidence rate for the corresponding country. Visual inspection of
temporal figures and calculation of Pearson correlation coefficients were performed.
Results: Global measles exposure was similar in Ontario and Quebec. In Quebec, there was a nearly perfectly linear
relationship between annual measles cases and its global measles exposure index over 2007–2011 (r = 0.99, p = 0.001).
In contrast, there was a non-significant association in Ontario. The 2011 rise in Quebec’s index was largely driven by a
dramatic increase in measles activity in France the same year.
Conclusions: Global measles activity was associated with measles epidemiology in Quebec. Global measles exposure risk
is higher in Ontario than Quebec. Differences in measles epidemiology between Ontario and Quebec from 2007–2011
are not explained by greater exposure in Quebec. A combination of alternative factors may be responsible, including
differences in population susceptibility.
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Background
Measles is the most communicable of vaccine-preventable
diseases, requiring very high vaccine coverage for effective
control. The Pan American Health Organization (PAHO)
achieved its goal of endemic measles elimination by 2000
[1] and in Canada the last confirmed case of endemic
measles virus was reported in 1997 [2–4]. In countries
where elimination has been achieved, cases may still occur
due to travel (importations) and some imported cases may
result in limited local transmission (import-related cases).
Measles epidemiology during elimination is therefore influ-
enced by global measles activity and travel.
In Canada, measles vaccination policy and public health
actions for measles control are provincial/territorial and
regional responsibilities, respectively, and guidance on
disease control and immunization is federal [5, 6]. Mea-
sles is reportable in all 13 of Canada’s provinces and terri-
tories (P/Ts) [2] and all have a 2 dose measles vaccine
policy. These measures successfully kept the annual inci-
dence of measles from 0.02 to 0.31 per 100,000 from 2001
to 2010, with annual numbers of cases ranging from 6
(2005) to 102 (2007) [7]. In 2011, however, the province
of Quebec experienced the largest measles outbreak in
the region of the Americas in a decade with 725 con-
firmed cases reported between January 8 and December
22, 2011. In contrast, neighbouring Ontario confirmed a
total of 8 measles cases in 2011 [8]. Ontario and Quebec* Correspondence: sarah.wilson@oahpp.ca
1Public Health Ontario, Toronto, ON, Canada
2Dalla Lana School of Public Health, University of Toronto, Toronto, ON,
Canada
Full list of author information is available at the end of the article
© 2015 Wilson et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a
link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this
article, unless otherwise stated.
Wilson et al. BMC Infectious Diseases  (2015) 15:341 
DOI 10.1186/s12879-015-1039-0
are Canada’s two most populous provinces with popula-
tion sizes of 13.5 and 8.2 million, respectively.
Public health officials in Quebec attributed the 2011
measles outbreak to a combination of a chance super-
spreading event and sub-optimal measles immunity [9].
Our objective was to assess the contribution of travel pat-
terns to the difference in measles epidemiology between
the two provinces through a descriptive analysis and by
exploring a new measure, the measles exposure index. We
did this by comparing international travel and measles
activity among the source countries of travelers arriving
via commercial flights to Ontario and Quebec, to the mea-
sles epidemiology of each respective province over the
period of 2007 to 2011. With the exception of the United
States (US) (where measles has also been eliminated),
international travel to and from Canada occurs almost ex-
clusively by air rather than other modes of transport [10].
Methods
Provincial reportable disease surveillance systems, the
integrated Public Health Information System (iPHIS) in
Ontario and the Maladies à Déclaration Obligatoire
(MADO) in Quebec, provided measles cases reported
between 2007 and 2011. We analysed cases meeting the
provincial confirmed surveillance case definition, com-
prising laboratory-confirmed measles cases plus cases
with clinically compatible signs and symptoms who are
epidemiologically linked to a laboratory-confirmed case
in both provinces [11, 12]. In Canada, laboratory con-
firmation requires isolation of measles virus, detection
of measles virus ribonucleic acid (RNA), or a significant
rise in measles immunoglobulin G (IgG) titre between
acute and convalescent sera [5, 11, 12]. A positive sero-
logic test for measles immunoglobulin M (IgM) antibody
meets the criteria of a confirmed case only if there is an
epidemiologic link to a lab-confirmed case, or a travel
history to an area of known measles activity [5, 11, 12].
In both provinces, cases are imported if they have trav-
elled outside Canada in the 7–21 days prior to symptom
onset [5, 11, 12]. Import-related cases have acquired in-
fection in Ontario or Quebec and are epidemiologically-
linked to another case that travelled in the 7–21 days
prior to symptom onset. Unknown importation status is
assigned if exposure fields, case notes, comments, or
client travel file make no reference to travel, and no
clear epidemiological links made to other cases. Popula-
tion data for crude incidence rates came from Statistics
Canada, accessed through intelliHealth Ontario, and
from the Institut de la statistique du Quebec [13].
We measured measles importation risk using Inter-
national Air Transport Association (IATA) [14] anon-
ymized flight itineraries of all travelers who embarked
on commercial flights, including scheduled charters,
from outside Canada with a final destination of Ontario
or Quebec over the period of 2007–2011. Each flight it-
inerary encompasses data on the city where each traveler
initiated their trip, along with all connecting flights en
route to their final destination. Due to its anonymized
nature, it is not possible to discern whether travelers are
returning home or visitors.
We created a bivariate choropleth map for each prov-
ince to estimate the spatial distribution of measles import-
ation risk in Ontario and Quebec. These maps combine
the country-specific measles incidence rates in 2011 from
WHO, with the corresponding traveler volume from each
country into Ontario and Quebec in 2011.
An ecological analysis quantitatively compared the cu-
mulative risk of measles importation between Ontario and
Quebec using a measles exposure index derived by multi-
plying the monthly traveler volume for each country into
Quebec or Ontario by the annual measles incidence rate
for the corresponding country, obtained from WHO. As
monthly measles incidence is not available for many coun-
tries, the annual country-specific measles incidence rate
was used as a proxy for each month of the relevant year.
The formula for the index is shown in Box 1. For sensitiv-
ity analysis, the index was calculated for travel from
France to Quebec for 2011 using monthly traveler volume
and monthly measles incidence rates obtained from the
European Centre for Disease Control. We assessed sea-
sonality in Quebec and Ontario using temporal graphs
illustrating monthly provincial measles activity from
2007–2011. The association between the annual num-
ber of importations and the annual global measles ex-
posure index for each province was evaluated using
Pearson correlation coefficients in STATA (version
12.1). We also did this comparing the monthly number
of importations and the monthly measles exposures
index value for each province, with and without a time
lag of one month given that the maximum incubation
period of measles is 21 days. In Quebec we calculated
the Pearson correlation coefficient between monthly
imported cases in 2011 and the measles exposure index
related to travel from France. We explored the impact
of measles cases of unknown source on the degree of
association in all analyses. We made a multi-year com-
parison between Ontario and Quebec using monthly
indices summed from 2007 to 2011 to provide an
aggregate value. Finally, we identified individual coun-
tries with the greatest influence on the value of the
2011 global index of exposure for both provinces.
Box 1. Formula to calculate the measles exposure
index for country X to Quebec
∑[(Monthly traveler volume from X to Quebec) × (Monthly
measles incidence in X)] January, February...December
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As we used aggregate routine surveillance data, re-
search ethics committee approval was not required
under the Ontario Agency for Health Protection and Pro-
motion Act [15]. In Quebec, the Research Ethics Board
of the Laval University Research Hospital Center pro-
vided an exemption letter, and all 18 Regional Directors
of Public Health provided permission for the disclosure
of aggregate measles data to the study team. All analyses
were conducted on aggregate, rather than individual
level data, routinely collected for the purposes of mea-
sles surveillance; thus, individual level informed consent
was not obtained.
Results
Between 2007 and 2011, the annual number of con-
firmed measles cases in Ontario ranged from a low of
zero in 2007 to a peak of 58 cases in 2008 (Table 1). Be-
tween March and June 2008, an outbreak involving 54
cases occurred in southern Ontario. Although the source
case was never determined, the outbreak was suspected
to be import-related because of common exposure to a
major tourist destination in Toronto and the identifica-
tion of measles genotype D8 [16], associated with en-
demic transmission in the Southeast Asian and Eastern
Mediterranean Regions [17]. Nevertheless, cases were
classified as having an unknown source. In the province
of Quebec, the annual number of confirmed cases
ranged from 1 in 2008 to 725 in 2011 (Table 2). The
epidemiologic characteristics of the 2011 outbreak are
described in detail elsewhere [9]. Over the period of
2007–2011, 68.3 % (56/82) cases in Ontario and 3.1 %
(26/832) cases in Quebec were of unknown source
(Tables 1 and 2). In Ontario, 54 of the 56 cases with
unknown source were from the same 2008 outbreak.
In 2011, the measles exposure index was 117 for
Ontario and 151 for Quebec. Countries presenting the
greatest risk of exposure to measles, on the basis of
national measles incidence and corresponding passenger
volume, were similar for both provinces although the
index values differed (Fig. 1a and b). The top three
countries contributing to Ontario’s 2011 measles expos-
ure index (index values in parentheses) were: France
(34.4), Italy (15.4) and the United Kingdom (8.5). The
rank order (and values) for Quebec in 2011 were: France
(107.4), Italy (9.1) and Spain (6.2). Although France was
the greatest contributor to the exposure index for both
provinces in 2011 it was much more influential for Que-
bec accounting for 71 % of the index in that province, as
compared to 29 % in Ontario.
In both provinces, regular seasonal travel patterns
were observed with traveler volume peaking annually in
the summer months with a smaller peak in March coin-
ciding with school holidays (Additional file 1: Figure
S4A and Additional file 2: Figure S4B). The maximum
monthly inbound traveler volumes are approximately
twice as high in Ontario as compared to that observed
in Quebec. Over the summer months of 2010 and 2011,
the monthly inbound volume into Ontario was more
than 800,000 passengers, with approximately 400,000
travelers per month flying into Quebec. No obvious tem-
poral relationship existed between monthly inbound
traveler volumes and measles cases in either province.
Comparing provincial measles activity in relation to
each province’s respective global measles exposure index
(Fig. 2a and b) shows fluctuation over the period of
2007–2010, with an increase in 2011. The annual values
for the measles exposure index for the two provinces
and the mean and range of country-specific values are
shown in Table 3. The cumulative measles exposure
Table 1 Confirmed Ontario measles cases by importation status and crude measles incidence rate per 100,000 population, 2007-2011
2007 2008 2009 2010 2011 Total
Case classification Cases Crude rate Cases Crude rate Cases Crude rate Cases Crude rate Cases Crude rate Cases
Imported 0 0.00 3 0.02 1 0.01 4 0.03 4 0.03 12
Import-related 0 0.00 0 0.00 5 0.04 5 0.04 4 0.03 14
Unknown 0 0.00 55 0.43 1 0.01 0 0.00 0 0.00 56
Total 0 0.00 58 0.45 7 0.05 9 0.07 8 0.06 82
Table 2 Confirmed Quebec measles cases by importation status and crude measles incidence rate per 100,000 population, 2007-2011
2007 2008 2009 2010 2011 Total
Case classification Cases Crude rate Cases Crude rate Cases Crude rate Cases Crude rate Cases Crude rate Cases
Imported 0 0.00 1 0.01 2 0.03 3 0.04 17 0.21 23
Import-related 87 1.14 0 0.00 4 0.05 1 0.01 691 8.67 783
Unknown 9 0.12 0 0.00 0 0.00 0 0.00 17 0.21 26
Total 96 1.25 1 0.01 6 0.08 4 0.05 725 9.10 832
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index over the study period was 386 for the province of
Ontario, and 335 for Quebec suggesting that Ontario has
a slightly greater overall global exposure to measles
importation than Quebec. Over the same period there
were a total of 13 measles importations in Ontario and 23
importations in Quebec (Table 1). If both imported and
unknown cases are combined, a total of 68 cases were
reported in Ontario and 49 in Quebec over the period of
A
B
Fig. 1 a Global Risk of Measles Importation into Ontario, Canada, 2011. b Global Risk of Measles Importation into Quebec, Canada, 2011. Data
Source: WHO/World Bank, 2011; IATA, 2011
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2007–2011. The annual measles exposure index correlated
non-significantly with annual measles importations in
Ontario (Pearson correlation coefficient, (r = 0.75, p =
0.15)) but correlated almost perfectly in Quebec (r = 0.99,
p = 0.001). When comparing the degree of association
between monthly measles exposure index and monthly
measles importations, the strength of the relationship was
attenuated but remained significant in Quebec (r = 0.48, p
= 0.0001) and remained non-significant in Ontario (r =
0.04, p = 0.79). The lagged monthly analyses demonstrated
similar findings for both provinces. Adding cases of un-
known source to importations resulted in small changes
to the coefficients in all analyses examining monthly data
but did not change the significance of any findings.
A
B
Fig. 2 a Ontario measles cases (importations and unknown source) and global measles exposure index values, 2007–2011. b Quebec measles
cases (importations and unknown source) and global measles exposure index values, 2007–2011
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In both Ontario and Quebec, the global measles ex-
posure index increased greatly in 2011. Figure 3 depicts
the most influential countries of origin in driving the
value of the global measles exposure index for Quebec
(Fig. 3a) and Ontario (Fig. 3b) over the study period. In
both provinces, the rise in the index in 2011 was mainly
driven by a measles epidemic in France, with greater
influence in Quebec than in Ontario due to much larger
passenger volumes. In 2011, France reported 14,966
measles cases, resulting in the highest crude incidence
rate in the European Union at 23.0 cases per 100,000
population [18]. A measles exposure index calculated
specifically for travel from France in 2011 correlated
poorly with monthly case counts of measles importations
in Quebec (r = 0.34, p = 0.28). The coefficient increased
minimally when importations plus cases of unknown
source were examined (r = 0.38, p = 0.23). Over the course
of 2011, 4 measles importations occurred in Ontario (zero
with an unknown source), compared with 17 importa-
tions to Quebec and an additional 17 measles cases of
unknown source of acquisition (Tables 1 and 2).
Discussion
Measles activity in areas from which there is frequent
travel to Canada presents a significant challenge to sus-
taining elimination [2, 3]. Measles importations are ex-
pected, but the risk of importation is not constant over
time. Over the course of 2013 and into 2014, Canada
has observed increased numbers of measles importations
and import-related cases, reflecting the extent of global
measles activity [19–21]. Only one of these cases occurred
in Quebec (one case in 2013 and zero measles incidence
in 2014) [Vladimir Gilca, personal communication]. In
contrast, Ontario observed a total of 15 cases in 2013 [22]
and 22 in 2014 [Shelley Deeks, personal communication].
The public health actions to control measles and subse-
quent import-related cases are costly [23].
Our analysis suggests that the risk of measles importa-
tions can be estimated through measles surveillance in
countries with close travel links, and quantified through
the calculation of a measles exposure index. The find-
ings are consistent with those of a study of measles im-
portation into the United States via airline travelers that
estimated 24 importations per year in the United States,
very similar to the observed frequency of importations
of 28 per year [24]. This analysis found a weaker associ-
ation between the global measles exposure index and
measles importations in Ontario than in Quebec, with
several possible explanations. Firstly, the quality of mea-
sles surveillance data could be lower in Ontario, but it is
unlikely that a large outbreak would go undetected. Other
possible explanations for a lower risk of measles out-
breaks in Ontario include higher immunity due to a com-
bination of higher vaccine uptake and greater proportion
of immigrants from measles endemic countries [25], who
are more likely to have immunity from natural infection.
Differences in measles susceptibility are unlikely to be
explained by differing age structures as the proportion of
the population ≥ 40 years of age in 2011 was similar
(49.5 % in Ontario, 51.8 % in Quebec) [13, 26]. Individuals
born prior to 1970 are likely to be immune [5].
The 2011 Quebec outbreak illustrates the importance of
understanding the risk of local transmission following
measles importation. Key to this is having high quality sys-
tems of coverage and population susceptibility monitoring.
During the 2011 Quebec outbreak, because immunization
coverage was thought to be high enough to prevent
sustained transmission, public health authorities initially
focused on offering vaccine or immunoglobulin to individ-
uals at high risk of measles complications and unva-
ccinated close contacts, rather than initiating wide-scale
supplementary immunization [9]. Provincial coverage esti-
mates among 28-month–old children in Quebec reported
90 % 2 dose measles coverage and 97 % 1 dose coverage,
with similar estimates at a regional level [27]. This is simi-
lar to coverage estimates in Ontario, where 2-dose measles
vaccine coverage was 89 % among 7-year-olds and 95 %
among 17-year-olds in the 2011/12 school year [28].
Lower coverage among the student population (85 % with
written documentation of receipt of 2 doses, with add-
itional susceptibility among 1 dose recipients), and a pos-
tulated superspreader event within this community may
have played a crucial role in the outbreak [9]. An add-
itional explanation to the more limited extent of import-
associated cases in Ontario may be the Immunization of
School Pupils Act, provincial legislation that enables un-
immunized students to be excluded from school during
an outbreak [29].
Table 3 Measles exposure index, annual totals and country-specific
values, Ontario and Quebec, 2007-2011
Province Year Total Country-specific values
Minimum Maximum Mean
Ontario 2007 56.9 0.0 12.7 0.32
2008 85.1 0.0 16.1 0.47
2009 55.2 0.0 9.1 0.31
2010 71.0 0.0 18.0 0.39
2011 117.4 0.0 34.4 0.65
2007-2011 385.5 0.0 49.7 2.14
Quebec 2007 26.2 0.0 6.6 0.15
2008 41.0 0.0 12.9 0.23
2009 51.4 0.0 19.0 0.29
2010 65.4 0.0 33.4 0.37
2011 151.3 0.0 107.4 0.85
2007-2011 335.3 0.0 154.5 1.87
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The strengths of this assessment include the availability
of detailed measles surveillance data from Canada’s two
most populous provinces, and the integration of these
data with comprehensive international travel data. Limita-
tions include that this is an ecological analysis, and our
single risk measure combined travel patterns and measles
incidence in the source country. We cannot discern from
IATA data whether travelers are visitors or Canadians
returning home from abroad, the length and nature of the
travel, nor the ages of travelers. These attributes influ-
ence the likelihood of susceptibility and infection and
would help refine our risk estimates if available. We
did not adjust for the population size of the two prov-
inces as our outcome of interest was the number of
measles importations. Finally, cross-border non-air
travel from the US into Canada was not included, but
A
B
Fig. 3 a Measles exposure index for Quebec by source country of arriving travelers, 2007–2011. b Measles exposure index for Ontario by source
country of arriving travelers, 2007–2011
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is unlikely to be important since measles is eliminated
in the US.
A further limitation is that WHO provides only annual
country-specific measles incidence rates, while traveler
volume is available monthly. Monthly measles incidence
would have allowed for a more granular measurement of
global measles exposure for each province, including de-
tecting monthly changes in risk. Finally, this assessment
would have been bolstered by an accompanying analysis
of measles susceptibility between the two provinces.
Future directions for research involving the measles
exposure index should expand on the descriptive, proof
of concept work, described here and test the perform-
ance of the index in predicting the number of measles
importations using statistical modelling, controlling for
population measles susceptibility and other important
covariates, and using an expanded dataset including a larger
number of importations.
Conclusions
The 2011 measles epidemic in France may have been an
important cause of the Quebec outbreak, but our findings
indicate that characteristics of the provincial measles
susceptibility were more important in determining outbreak
size. Over 2007–2011 Ontario had a higher degree of global
exposure to measles, with relatively few cases, suggesting
high herd immunity. Improvements in measles surveillance
data quality, vaccine coverage assessment, and the estab-
lishment of a measles sero-epidemiology program in
Canada [30], would help elucidate the risk importations
pose to sustaining measles elimination in Canada. Future
work to examine the performance of the measles exposure
index in predicting measles cases in the post-elimination
era is warranted.
Additional files
Additional file 1: Figure S4A. Quebec measles cases (importations and
unknown source) and inbound passenger volume, 2007–2011. (PPTX 18 kb)
Additional file 2: Figure S4B. Ontario measles cases (importations and
unknown source) and inbound passenger volume, 2007–2011. (PPTX 18 kb)
Abbreviations
IATA: International Air Transportation Association; IgG: Immunoglobulin G;
IgM: Immunoglobulin M; iPHIS: integrated Public Health Information System;
MADO: Maladies à Déclaration Obligatoire; PAHO: Pan American Health
Organization; P/Ts: Provinces and territories; RNA: Ribonucleic acid;
WHO: World Health Organization.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
NC conceived of the study. NC, SD, VG and KK contributed to the
development of the proposal. RE and JM led the data analysis with GL and
SW involved in supplementary analyses. SW wrote the first draft of the
manuscript. All authors (SW, KK, VG, JM, SD, GL, RE, SB, NC) significantly
contributed to epidemiological interpretation of data and revising of the
manuscript and have approved the final version. All authors agree to act as
guarantors to the work.
Acknowledgements
Thank you to Dr. Gaston De Serres for helpful discussion of the 2011 Quebec
outbreak cases. Sincere thanks to Marisa Creatore, Caitlin Johnson, Adrian
Nicolucci and Chi Yon Seo for their assistance with additional analyses and
figure preparation. This project was funded through the Project Initiation
Fund of Public Health Ontario.
Author details
1Public Health Ontario, Toronto, ON, Canada. 2Dalla Lana School of Public
Health, University of Toronto, Toronto, ON, Canada. 3St Michael’s Hospital,
Department of Medicine, Division of Infectious Diseases, Toronto, ON,
Canada. 4Centre for Research on Inner City Health, Keenan Research Centre,
Li Ka Shing Knowledge Institute, Toronto, ON, Canada. 5Faculty of Medicine,
Division of Infectious Diseases, University of Toronto, Toronto, ON, Canada.
6Institut national de santé publique du Québec, Québec, QC, Canada.
7Université Laval, Laval, QC, Canada. 8Department of Laboratory Medicine
and Pathobiology, University of Toronto, Toronto, ON, Canada.
Received: 17 November 2014 Accepted: 17 July 2015
References
1. Meeting on Vaccine-preventable Diseases of the Pan American Health
Organization: Final report of the XIX Technical Advisory Group [TAG].
Argentina; 2011. Available at: www.paho.org/immunization/toolkit/
resources/tech-recommendations/TAG-2011.pdf.
2. Public Health Agency of Canada. Elimination of measles, rubella and
congenital rubella syndrome in Canada. Documentation and verification
report: Public Health Agency of Canada, Ottawa. December; 2011.
3. Papania MJ, Wallace GS, Rota PA, Icenogle JP, Fiebelkorn AP, Armstrong GL,
et al. Elimination of endemic measles, rubella, and congenital rubella
syndrome from the Western Hemisphere: The US experience. JAMA Pediatr
2013, doi:10.1001/jamapediatrics.2013.4342.
4. Pan American Health Organization. Plan of action documentation and
verification of measles, rubella, and congenital rubella syndrome elimination
in the Region of the Americas. Technical Document. December; 2010.
www.paho.org/hq/
index.php?option=com_docman&task=doc_download&gid=16739.
5. An Advisory Committee Statement: Measles and Rubella Elimination
Working Group. Guidelines for the prevention and control of measles
outbreaks in Canada. CCDR. 2013;39(3):1–52.
6. Canadian Immunization Guide: Measles vaccine. Available at:
http://www.phac-aspc.gc.ca/publicat/cig-gci/p04-meas-roug-eng.php.
[cited February 4, 2014]
7. Public Health Agency of Canada: Measles. http://www.phac-aspc.gc.ca/im/
vpd-mev/measles-rougeole-eng.php. [cited Dec. 17, 2013]
8. Lim GH, Deeks SL, Fediurek J, Gubbay J, Crowcroft NS. Documenting the
elimination of measles, rubella and congenital rubella syndrome in Ontario.
CCDR. 2009–2012;2011:40–8.
9. De Serres G, Markowski F, Toth E, Landry M, Auger D, Mercier M, et al.
Largest measles epidemic in North America in a decade–Quebec, Canada,
2011: contribution of susceptibility, serendipity, and superspreading events.
J Infect Dis. 2013;207(6):990–8.
10. Tourism Industry of Canada. The Canadian Tourism Industry: A Special
Report, Fall 2012. Available at: http://tiac.travel/_Library/documents/
The_Canadian_Tourism_Industry_-_A_Special_Report_Web_Optimized_.pdf.
11. Ministry of Health and Long-Term Care. Infectious diseases protocol.
Toronto: Queen’s Printer for Ontario; 2013. Available from: http://
www.health.gov.on.ca/en/pro/programs/publichealth/oph_standards/
infdispro.aspx.
12. La Direction des communications du ministère de la Santé et des
Services sociaux du Québec. Fishe technique pour la gestion des cas de
rougeole et des contacts. Québec: Gouvernement du Québec; 2012.
Available from: http://collections.banq.qc.ca/ark:/52327/bs2105544.
Wilson et al. BMC Infectious Diseases  (2015) 15:341 Page 8 of 9
13. Institut de la statistique du Quebec. Le bilan demographique du Quebec.
Édition 2011. Available from: http://www.bdso.gouv.qc.ca/docs-ken/
multimedia/PB01614FR_Bilandemo2011F00.pdf.
14. International Air Transport Association. Airport Intelligence Services
(Airport IS)-Passenger Data. [http://www.iata.org/services/statistics/
intelligence/airportis/Pages/index.aspx]
15. OAHPP Act: SO 2007, c 10. [http://www.e-laws.gov.on.ca/html/statutes/
english/elaws_statutes_07o10_e.htm]
16. Finkelstein M, Crowcroft N, Kadri O, Yaffe B, Dubey V. Epidemiology of
measles outbreak in Toronto. Toronto, Ontario, Canada: Oral presentation at
the 8th Canadian Immunization Conference; 2008.
17. Rota PA, Brown K, Mankertz A, Santibanez S, Shulga S, Muller CP, et al.
Global distribution of measles genotypes and measles molecular
epidemiology. J Infect Dis. 2011;204 Suppl 1:S514–23.
18. 18.European Centre for Disease Control. 2013 Annual epidemiological report:
Reporting on 2011 surveillance data and 2012 epidemic intelligence data.
[http://www.ecdc.europa.eu/en/publications/Publications/annual-
epidemiological-report-2013.pdf]
19. Public Health Agency of Canada. Public Health Notice: Measles. [http://
www.phac-aspc.gc.ca/phn-asp/2013/measles-0717-eng.php]
20. Alberta Health Services. Measles Information. CBC News. Southern Alberta
measles outbreak up to 40 confirmed cases. November 21, 2013.http://
www.cbc.ca/news/canada/calgary/southern-alberta-measles-outbreak-up-to-
40-confirmed-cases-1.2436030]
21. Fraser Health. Measles outbreak declared over October 23, 2013.
[http://www.fraserhealth.ca/your_health/mhoupdates/archive/2013-
archive/measles-outbreak-declared-over-oct-23%2C-2013]
22. Public Health Ontario. Ontario Health Profile: Measles. http://www.public
healthontario.ca/en/eRepository/OHP_infog_Measles_2014.pdf.
23. Ortega-Sanchez IR, Vijayaraghavan M, Barskey AE, Wallace GS. The economic
burden of sixteen measles outbreaks on United States public health
departments in 2011. Vaccine. 2013;32(11):1311–7.
24. Armstrong GL, Barskey AE, Redd S, Khan KM, Gallagher NM, Wallace G.
Modeling the Risk of Importation of Measles into the Americas. Atlanta, GA:
Poster presentation at International Conference on Emerging Infectious
Diseases [ICEID]; 2102.
25. Citizenship and Immigration Canada: Facts and figures 2012 – Immigration
overview: Permanent and temporary residents. [http://publications.gc.ca/
collections/collection_2013/cic/Ci1-8-2012-eng.pdf]
26. Population Estimates [2011], Ontario Ministry of Health and Long-Term Care,
IntelliHEALTH Ontario, Date Extracted: [2013/09/16].
27. Boulianne N, Bradet R, Audet D, Deceuninck G. Enquête sur la couverture
vaccinale des enfants de 1 an et 2 ans au Québec en 2008. Quebec City,
Canada: Institut National de Santé Publique du Québec; 2009. Available at:
http://www.inspq.qc.ca/pdf/publications/1045_CouverturVaccinEnfants1et
2Ans2008.pdf.
28. Ontario Agency for Health Protection and Promotion [Public Health
Ontario]. Immunization coverage report for school pupils 2011–12 school
year. Toronto, ON: Queen’s Printer for Ontario; 2013.
29. Immunization of School Pupils Act, R.S.O. 1990, cl. 1.
30. Wilson SE, Deeks SL, Hatchette TF, Crowcroft NS. The role of seroepidemiology
in the comprehensive surveillance of vaccine-preventable diseases. CMAJ.
2012;184(1):E70–6.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Wilson et al. BMC Infectious Diseases  (2015) 15:341 Page 9 of 9
